Peroxisome proliferator-activated receptor-alpha is required for the neurotrophic effect of oleic acid in neurons

Journal of Neurochemistry

Volumn 103, Issue 3, 2007, Pages 871-881

  Bento Abreu, André ^a   Tabernero, Arantxa ^a   Medina, José M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Central nervous system; Growth associated protein 43; Microtubule associated protein 2; Neuronal differentiation; Oleoylethanolamide; Small interfering RNA

Indexed keywords

4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; GW 7647; MICROTUBULE ASSOCIATED PROTEIN 2; N OLEOYLETHANOLAMINE; NEUROMODULIN; OLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIRINIXIC ACID; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; NERVE CELL; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BUTYRIC ACIDS; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; GAP-43 PROTEIN; GROWTH CONES; MICROTUBULE-ASSOCIATED PROTEINS; NERVE GROWTH FACTORS; NEURITES; NEURONS; OLEIC ACID; PHENYLUREA COMPOUNDS; PPAR ALPHA; PYRIMIDINES; RATS; RATS, WISTAR; RNA, SMALL INTERFERING;

EID: 35248894807     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04807.x     Document Type: Article

References (47)

1. Benowitz L. I. Routtenberg A. (1997) GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20, 84 91.
2. Berger J., Leibowitz M. D., Doebber T. W. et al. (1999) Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. J. Biol. Chem. 274, 6718 6725.
3. Blanquart C., Mansouri R., Paumelle R., Fruchart J. C., Staels B. Glineur C. (2004) The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha. Mol. Endocrinol. 18, 1906 1918.
4. Braissant O., Foufelle F., Scotto C., Dauca M. Wahli W. (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354 366.
5. Brown P. J., Chapman J. M., Oplinger J. A., Stuart L. W., Wilson T. M. Wu Z. (2000) Chemical compounds as selective activators of PPAR-alpha. PCT Int. Appl. 32.
6. Cáceres A., Banker G., Steward O., Binder L. Payne M. (1984) MAP2 is localized to the dendrites of hippocampal neurons which develop in culture. Brain Res. 315, 314 318.
7. Cáceres A., Banker G. A. Binder L. (1986) Immunocytochemical localization of tubulin and microtubule-associated protein 2 during the development of hippocampal neurons in culture. J. Neurosci. 6, 714 722.
8. Cimini A., Benedetti E., Cristiano L., Sebastiani P., D'Amico M. A., D'Angelo B. Di Loreto S. (2005) Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 130, 325 337.
9. Cullingford T. E., Bhakoo K., Peuchen S., Dolphin C. T., Patel R. Clark J. B. (1998) Distribution of mRNAs encoding the peroxisome proliferator- activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J. Neurochem. 70, 1366 1375.
10. Daynes R. A. Jones D. C. (2002) Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2, 748 759.
11. Deplanque D., Gele P., Petrault O. et al. (2003) Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J. Neurosci. 23, 6264 6271.
12. Desvergne B. Wahli W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649 688.
13. Desvergne B., Michalik L. Wahli W. (2004) Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol. Endocrinol. 18, 1321 1332.
14. Dinsmore J. H. Solomon F. (1991) Inhibition of MAP-2 expression affects both morphological and cell division phenotypes of neuronal differentiation. Cell 64, 817 826.
15. Dowell P., Peterson V. J., Zabriskie T. M. Leid M. (1997) Ligand-induced peroxisome proliferator-activated receptor alpha conformational change. J. Biol. Chem. 272, 2013 2020.
16. Eichholtz T., de Bont D. B., de Widt J., Liskamp R. M. Ploegh H. L. (1993) A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J. Biol. Chem. 268, 1982 1986.
17. Evans R. M., Barish G. D. Wang Y. X. (2004) PPARs and the complex journey to obesity. Nat. Med. 10, 355 361.
18. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M. Evans R. M. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803 812.
19. Forman B. M., Chen J. Evans R. M. (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl Acad. Sci. USA 94, 4312 4317.
20. Fu J., Gaetani S., Oveisi F. et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425, 90 93.
21. Gottlicher M., Widmark E., Li Q. Gustafsson J. A. (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA 89, 4653 4657.
22. Granda B., Tabernero A., Tello V. Medina J. M. (2003) Oleic acid induces GAP-43 expression through a protein kinase C-mediated mechanism that is independent of NGF but synergistic with NT-3 and NT-4/5. Brain Res. 988, 1 8.
23. Gray J. P., Burns K. A., Leas T. L., Perdew G. H. Vanden Heuvel J. P. (2005) Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C. Biochemistry 44, 10313 10321.
24. Grommes C., Landreth G. E. Heneka M. T. (2004) Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol. 5, 419 429.
25. Guzman M., Lo Verme J., Fu J., Oveisi F., Blazquez C. Piomelli D. (2004) Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J. Biol. Chem. 279, 27849 27854.
26. Hostetler H. A., Petrescu A. D., Kier A. B. Schroeder F. (2005) Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands. J. Biol. Chem. 280, 18667 18682.
27. Kainu T., Wikstrom A. C., Gustafsson J. A. Pelto-Huikko M. (1994) Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 5, 2481 2485.
28. Kersten S., Desvergne B. Wahli W. (2000) Roles of PPARs in health and disease. Nature 405, 421 424.
29. Kliewer S. A., Sundseth S. S., Jones S. A. et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl Acad. Sci. USA 94, 4318 4323.
30. Medina J. M. Tabernero A. (2002) Astrocyte-synthesized oleic acid behaves as a neurotrophic factor for neurons. J. Physiol. Paris 96, 265 271.
31. Michalik L., Desvergne B. Wahli W. (2004) Peroxisome-proliferator- activated receptors and cancers: complex stories. Nat. Rev. Cancer 4, 61 70.
32. Mollgard K., Dziegielewska K. M., Saunders N. R., Zakut H. Soreq H. (1988) Synthesis and localization of plasma proteins in the developing human brain. Dev. Biol. 128, 207 221.
33. Oestreicher B. A., De Graan P. N. E., Gispen H. W., Verhaagen J. Schrama L. H. (1997) B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system. Prog. Neurobiol. 53, 627 686.
34. Park K. S., Lee R. D., Kang S. K. et al. (2004) Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. Exp. Cell Res. 297, 424 433.
35. Rodríguez-Rodríguez R. A., Tabernero A., Velasco A., Lavado E. M. Medina J. M. (2004) The neurotrophic effect of oleic acid includes dendritic differentiation and the expression of the neuronal basic helix-loop-helix transcription factor NeuroD2. J. Neurochem. 88, 1041 1051.
36. Santos M. J., Quintanilla R. A., Toro A., Grandy R., Dinamarca M. C., Godoy J. A. Inestrosa N. C. (2005) Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J. Biol. Chem. 280, 41057 41068.
37. Saunders N. R. Mollgard K. (1981) The natural internal environment of the developing brain beyond the barrier. Trends Neurosci. 4, 56 60.
38. Schoonjans K., Staels B. Auwerx J. (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37, 907 925.
39. Skene J. H. P. (1989) Axonal growth-associated proteins. Ann. Rev. Neurosci. 12, 127 156.
40. Tabernero A., Jimenez C., Velasco A., Giaume C. Medina J. M. (2001a) The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation. J. Neurochem. 78, 890 898.
41. Tabernero A., Lavado E. M., Granda B., Velasco A. Medina J. M. (2001b) Neuronal differentiation is triggered by oleic acid synthesized and released by astrocytes. J. Neurochem. 79, 606 616.
42. Tabernero A., Velasco A., Granda B., Lavado E. M. Medina J. M. (2002) Transcytosis of albumin in astrocytes activates the sterol regulatory element-binding protein-1, which promotes the synthesis of the neurotrophic factor oleic acid. J. Biol. Chem. 277, 4240 4246.
43. Trojan J. Uriel J. (1979) [Intracellular localization of alpha-fetoprotein and serum albumin in the central nervous system of the rat during fetal and postnatal development]. C. R. Seances Acad. Sci. D 289, 1157 1160.
44. Velasco A., Tabernero A. Medina J. M. (2003) Role of oleic acid as a neurotrophic factor is supported in vivo by the expression of GAP-43 subsequent to the activation of SREBP-1 and the up-regulation of stearoyl-CoA desaturase during postnatal development of the brain. Brain Res. 977, 103 111.
45. Wada K., Nakajima A., Katayama K. et al. (2006) Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J. Biol. Chem. 281, 12673 12681.
46. Ward N. E. O'Brian C. A. (1993) Inhibition of protein kinase C by N-myristoylated peptide substrate analogs. Biochemistry 32, 11903 11909.
47. Zhang L. Chawla A. (2004) Role of PPARgamma in macrophage biology and atherosclerosis. Trends Endocrinol. Metab. 15, 500 505.